{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:45:13Z","timestamp":1779317113395,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jchf.2024.08.008","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:56:48Z","timestamp":1725091008000},"page":"58-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Race in Heart\u00a0Failure"],"prefix":"10.1016","volume":"13","author":[{"given":"Henri","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1883-0654","authenticated-orcid":false,"given":"Maria A.","family":"Pabon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eldrin F.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Zile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lefkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pardeep S.","family":"Jhund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jchf.2024.08.008_bib1","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jchf.2024.08.008_bib2","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1016\/S2214-109X(17)30196-1","article-title":"Global mortality variations in patients with heart failure: results from the International Congestive Heart\u00a0Failure (INTER-CHF) prospective cohort study","volume":"5","author":"Dokainish","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"25","key":"10.1016\/j.jchf.2024.08.008_bib3","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2021.06.058","article-title":"Race and ethnicity in heart failure: JACC Focus Seminar 8\/9","volume":"78","author":"Pi\u00f1a","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jchf.2024.08.008_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ejhf.1347","article-title":"Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas","volume":"21","author":"Dewan","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jchf.2024.08.008_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cardfail.2011.09.003","article-title":"Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific)","volume":"18","author":"Atherton","year":"2012","journal-title":"J\u00a0Card Fail"},{"issue":"8","key":"10.1016\/j.jchf.2024.08.008_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/eurjhf\/hft045","article-title":"Asian Sudden Cardiac Death in Heart\u00a0Failure (ASIAN-HF) registry","volume":"15","author":"Lam","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.jchf.2024.08.008_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007264","article-title":"Understanding the complexity of heart failure risk and treatment in Black patients","volume":"13","author":"Nayak","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.jchf.2024.08.008_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2022.0161","article-title":"Improving enrollment of underrepresented racial and ethnic populations in heart failure trials: a call to action from the Heart\u00a0Failure Collaboratory","volume":"7","author":"DeFilippis","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.jchf.2024.08.008_bib9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacasi.2023.05.010","article-title":"Asia-Pacific investigators and Asian enrollment in cardiometabolic trials: insights from publications between 2011 and 2020","volume":"3","author":"Azzopardi","year":"2023","journal-title":"JACC Asia"},{"issue":"12","key":"10.1016\/j.jchf.2024.08.008_bib10","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/jamacardio.2021.3651","article-title":"Potential implications of expanded US Food and Drug Administration labeling for sacubitril\/valsartan in the US","volume":"6","author":"Vaduganathan","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2024.08.008_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2018.03.121","article-title":"Angioedema in heart failure patients treated with sacubitril\/valsartan (LCZ696) or enalapril in the PARADIGM-HF study","volume":"264","author":"Shi","year":"2018","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.jchf.2024.08.008_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.jchf.2024.08.008_bib13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jchf.2024.08.008_bib14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ejhf.2421","article-title":"Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure","volume":"24","author":"Mc Causland","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"10.1016\/j.jchf.2024.08.008_bib15","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jchf.2024.08.008_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","article-title":"Sacubitril\/valsartan across the spectrum of ejection fraction in heart failure","volume":"141","author":"Solomon","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jchf.2024.08.008_bib17","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/ejhf.2262","article-title":"Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril\/valsartan in the PARAGON-HF trial","volume":"23","author":"Suzuki","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.jchf.2024.08.008_bib18","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ejhf.1130","article-title":"Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years","volume":"20","author":"Vaduganathan","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.jchf.2024.08.008_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jchf.2016.05.008","article-title":"Racial and ethnic differences in heart failure readmissions and mortality in a large municipal healthcare system","volume":"4","author":"Durstenfeld","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.1016\/j.jchf.2024.08.008_bib20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/jamacardio.2020.3654","article-title":"Trends in the prevalence of self-reported heart failure by race\/ethnicity and age from 2001 to 2016","volume":"5","author":"Rethy","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.jchf.2024.08.008_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jchf.2022.11.014","article-title":"Dapagliflozin in black and white patients with heart failure across the ejection fraction spectrum","volume":"11","author":"Butt","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.jchf.2024.08.008_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.122.062644","article-title":"Empagliflozin in Black versus White patients with heart failure: analysis of EMPEROR-Pooled","volume":"147","author":"Verma","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jchf.2024.08.008_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jacc.2021.11.024","article-title":"Race- and gender-based differences in cardiac structure and function and risk of heart failure","volume":"79","author":"Chandra","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jchf.2024.08.008_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003651","article-title":"Disparity between indications for and utilization of implantable cardioverter defibrillators in Asian patients with heart failure","volume":"10","author":"Chia","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.jchf.2024.08.008_bib25","article-title":"Contemporary reevaluation of race and ethnicity with outcomes in heart failure","volume":"10","author":"Savitz","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.jchf.2024.08.008_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jchf.2020.06.019","article-title":"Angiotensin-neprilysin inhibition in Black Americans: data from the PIONEER-HF trial","volume":"8","author":"Berardi","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.1016\/j.jchf.2024.08.008_bib27","article-title":"Angiotensin receptor neprilysin inhibition and associated outcomes by race and ethnicity in patients with heart failure with reduced ejection fraction: data from CHAMP-HF","volume":"11","author":"Chapman","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.jchf.2024.08.008_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007829","article-title":"Racial and ethnic differences in biomarkers, health status, and cardiac remodeling in patients with heart failure with reduced ejection fraction treated with sacubitril\/valsartan","volume":"13","author":"Ibrahim","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.jchf.2024.08.008_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group","volume":"5","author":"Carson","year":"1999","journal-title":"J\u00a0Card Fail"},{"issue":"18","key":"10.1016\/j.jchf.2024.08.008_bib30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM200105033441802","article-title":"Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction","volume":"344","author":"Exner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.jchf.2024.08.008_bib31","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.2024.6774","article-title":"Revisiting race and the benefit of RAS blockade in heart failure: a meta-analysis of randomized clinical trials","volume":"331","author":"Shen","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jchf.2024.08.008_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/CIRCHEARTFAILURE.111.965780","article-title":"Association of \u03b2-blocker exposure with outcomes in heart failure differs between African American and white patients","volume":"5","author":"Lanfear","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.jchf.2024.08.008_bib33","article-title":"Race and beta-blocker survival benefit in patients with heart failure: an investigation of self-reported race and proportion of African genetic ancestry","volume":"7","author":"Luzum","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2024.08.008_bib34","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/bmj.38803.528113.55","article-title":"Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine","volume":"332","author":"McDowell","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jchf.2024.08.008_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2020.08.067","article-title":"Angioedema with sacubitril\/valsartan: trial-level meta-analysis of over 14,000 patients and real-world evidence to date","volume":"323","author":"Dani","year":"2021","journal-title":"Int J Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924006097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924006097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T01:43:39Z","timestamp":1771897419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924006097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213177924006097"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.08.008","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Race in Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}